Systemic griseofulvin therapy of monilethrix.

Abstract

After a report of clinical effectiveness, four adult patients with monilethrix were treated with griseofulvin for six months at an orally administered dose of 500 mg (microsize) per day. No objective or subjective improvement was observed.

• Authors: E R Farmer, E A Murphy
• Journal: The Medical journal of Australia (Med J Aust) Vol. 2 Issue 2 Pg. 54 (Jul 15 1978) ISSN: 0025-729X [Print] Australia
• PMID: 713912 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Griseofulvin

Topics

• Adolescent
• Adult
• Female
• Griseofulvin (therapeutic use)
• Hair
• Humans
• Male
• Skin Diseases (drug therapy)